Everence Capital Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-16,530
| Closed | -$244K | – | 962 |
|
|
2024
Q3 | $244K | Sell |
16,530
-1,310
| -7% | -$19.3K | 0.02% | 665 |
|
|
2024
Q2 | $248 | Hold |
17,840
| – | – | 0.02% | 604 |
|
|
2024
Q1 | $280 | Hold |
17,840
| – | – | 0.02% | 589 |
|
|
2023
Q4 | $289K | Hold |
17,840
| – | – | 0.02% | 569 |
|
|
2023
Q3 | $219 | Hold |
17,840
| – | – | 0.02% | 635 |
|
|
2023
Q2 | $306K | Hold |
17,840
| – | – | 0.02% | 517 |
|
|
2023
Q1 | $311 | Hold |
17,840
| – | – | 0.03% | 525 |
|
|
2022
Q4 | $165 | Hold |
17,840
| – | – | 0.01% | 720 |
|
|
2022
Q3 | $154K | Hold |
17,840
| – | – | 0.01% | 686 |
|
|
2022
Q2 | $145K | Hold |
17,840
| – | – | 0.01% | 689 |
|
|
2022
Q1 | $217K | Hold |
17,840
| – | – | 0.02% | 666 |
|
|
2021
Q4 | $609K | Hold |
17,840
| – | – | 0.05% | 347 |
|
|
2021
Q3 | $861K | Hold |
17,840
| – | – | 0.07% | 228 |
|
|
2021
Q2 | $806K | Hold |
17,840
| – | – | 0.07% | 238 |
|
|
2021
Q1 | $860K | Sell |
17,840
-2,430
| -12% | -$117K | 0.08% | 209 |
|
|
2020
Q4 | $1.09M | Sell |
20,270
-1,930
| -9% | -$104K | 0.11% | 160 |
|
|
2020
Q3 | $819K | Buy |
22,200
+3,310
| +18% | +$122K | 0.09% | 180 |
|
|
2020
Q2 | $504K | Hold |
18,890
| – | – | 0.06% | 294 |
|
|
2020
Q1 | $522K | Hold |
18,890
| – | – | 0.07% | 228 |
|
|
2019
Q4 | $553K | Hold |
18,890
| – | – | 0.08% | 261 |
|
|
2019
Q3 | $361K | Hold |
18,890
| – | – | 0.06% | 368 |
|
|
2019
Q2 | $414K | Hold |
18,890
| – | – | 0.07% | 318 |
|
|
2019
Q1 | $386K | Buy |
+18,890
| New | +$386K | 0.07% | 327 |
|